VIPoma laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{PSD}} | {{CMG}}{{AE}}{{PSD}} | ||
==Overview== | ==Overview== | ||
Laboratory tests used in the diagnosis of VIPoma include serum vasoactive intestinal polypeptide (VIP) levels, basal gastric acid output, potassium, bicarbonate, magnesium, and calcium levels. | Laboratory tests used in the diagnosis of VIPoma include serum vasoactive intestinal polypeptide (VIP) levels, basal gastric acid output, potassium, bicarbonate, magnesium, and calcium levels.<ref name="pmid16357627">{{cite journal| author=Remme CA, de Groot GH, Schrijver G| title=Diagnosis and treatment of VIPoma in a female patient. | journal=Eur J Gastroenterol Hepatol | year= 2006 | volume= 18 | issue= 1 | pages= 93-9 | pmid=16357627 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16357627 }} </ref> | ||
==Laboratory Findings== | ==Laboratory Findings== | ||
Revision as of 18:50, 23 October 2015
|
VIPoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
VIPoma laboratory findings On the Web |
|
American Roentgen Ray Society Images of VIPoma laboratory findings |
|
Risk calculators and risk factors for VIPoma laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Laboratory tests used in the diagnosis of VIPoma include serum vasoactive intestinal polypeptide (VIP) levels, basal gastric acid output, potassium, bicarbonate, magnesium, and calcium levels.[1]
Laboratory Findings
- Serum vasoactive intestinal polypeptide (VIP) levels
- Pancreatic polypeptide levels and neurotensin levels
- Low serum potassium, bicarbonate, hypomagnesaemia, and hypercalcaemia levels secondary to faecal loss
- Low basal gastric acid output
References
- ↑ Remme CA, de Groot GH, Schrijver G (2006). "Diagnosis and treatment of VIPoma in a female patient". Eur J Gastroenterol Hepatol. 18 (1): 93–9. PMID 16357627.